PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Innovative risk score accurately calculates which kidney transplant candidates are also at risk for heart attack or stroke, new study finds

Innovative risk score accurately calculates which kidney transplant candidates are also at risk for heart attack or stroke, new study finds
2024-11-17
(Press-News.org) Using an innovative risk score assessment score, heart researchers at Intermountain Health in Salt Lake City say they can accurately predict whether patients being assessed for kidney transplant will likely have a future major cardiac event, like a heart attack or stroke, according to a new study.

Intermountain Health clinicians regularly review patient data through their electronic health system to determine who may have heart disease without knowing it. Now, in a major new study, Intermountain heart researchers found that using their Intermountain Risk Score (IMRS) they could also accurately predict whether patients being assessed for kidney transplant would have a major cardiac event, like a heart attack or stroke. 

“This study demonstrates that we could adapt our already existing risk score guide to help identify which of these patients might also be at risk for having a heart event, which could lead to better and more personalized treatment,” said Benjamin Horne, PhD, director of cardiovascular and genetic epidemiology at the Intermountain Health.  

Findings from the new study will be presented at the American Heart Association Scientific Sessions in Chicago on Sunday, November 17, 2024.

The Intermountain Risk Score is a well-validated, sex-specific risk prediction tool that includes factors like age and results from complete blood count and basic metabolic profile testing to predict the risk of major cardiovascular events and death.

These scores are assessed automatically based on information input into electronic health records. If a patient has a high score, their care team is alerted. 

In the Intermountain study, researchers looked specifically at the accuracy of the IMRS for patients being considered for kidney transplant.

They identified patients who were assessed for transplant surgery at Intermountain Health between June 2015 and April 2024 and found 891 patients. 200 patients did not have all of the laboratory tests needed to calculate an IMRS, so they were excluded from the next step in the study.

That left 691 patients with enough information to retroactively calculate IMRS.

Intermountain researchers found that these patients were on average 55.9 years old, and 34.3% were women.

Of those 691 patients, 171 experienced a major cardiac event over a five-year follow-up period. Researchers found that IMRS was effective in predicting these outcomes, showing the potential use of calculating such a score in people being evaluated for kidney transplant.

The score can be “a really valuable piece of information, but some of these patients were missing lab tests that would have enabled us to calculate it,” said Dr. Horne, referring to the 200 people in this retrospective study who did not have enough laboratory tests to be included. 

“This is the first step in assessing if we can make a risk score specifically keyed to the risk of people who are going to have a rental transplant, and make sure we collected all the appropriate data so we can do so,” he said.

Next steps include validating the risk score in another patient population, determining whether modifying the risk score by adding data routinely collected in kidney patients improves its ability to assess risk for kidney transplant patients, and then conducting a prospective clinical trial of using the risk score in modifying clinical care processes to determine whether personalized care improves patient outcomes.

                                                                              ###

 

END

[Attachments] See images for this press release:
Innovative risk score accurately calculates which kidney transplant candidates are also at risk for heart attack or stroke, new study finds

ELSE PRESS RELEASES FROM THIS DATE:

Kidney outcomes in transthyretin amyloid cardiomyopathy

2024-11-17
About The Study: In this retrospective cohort study, decline in kidney function was frequent in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) and was consistently associated with an increased risk of mortality, even after adjusting for established markers of worsening ATTR-CM. eGFR decline represents an independent marker of ATTR-CM disease progression that could guide treatment optimization in clinical practice.  Corresponding Author: To contact the corresponding author, Marianna Fontana, MD, PhD, email m.fontana@ucl.ac.uk. To access the embargoed study: ...

Partial cardiac denervation to prevent postoperative atrial fibrillation after coronary artery bypass grafting

2024-11-17
About The Study: This randomized clinical trial found that partial cardiac denervation was an effective procedure to reduce the occurrence of postoperative atrial fibrillation (POAF) after isolated coronary artery bypass grafting (CABG) without additional postoperative complications. These results suggest that partial cardiac denervation may be a good option for cardiac surgeons to consider for preventing POAF after CABG. Corresponding Authors: To contact the corresponding authors, email Wei Feng, MD, PhD (fengwei@fuwai.com) and Wei Zhao, MD, PhD (zhaowei_fw@163.com). To access the embargoed study: Visit our For The Media website at ...

Finerenone in women and men with heart failure with mildly reduced or preserved ejection fraction

2024-11-17
About The Study: In the Finerenone Trial to Investigate Efficacy and Safety Superior to Placebo in Patients with Heart Failure (FINEARTS-HF), finerenone reduced the risk of the primary end point similarly in women and men with heart failure with mildly reduced or preserved ejection fraction. Finerenone, a nonsteroidal mineralocorticoid receptor antagonist, had similar tolerability in women and men. Corresponding Author: To contact the corresponding author, John J. V. McMurray, MD, email john.mcmurray@glasgow.ac.uk. To ...

Finerenone, serum potassium, and clinical outcomes in heart failure with mildly reduced or preserved ejection fraction

2024-11-17
About The Study: In patients with heart failure with mildly reduced or preserved ejection fraction, finerenone, a nonsteroidal mineralocorticoid receptor antagonist, resulted in more frequent hyperkalemia and less frequent hypokalemia. However, with protocol-directed surveillance and dose adjustment, clinical benefit associated with finerenone relative to placebo was maintained even in those whose potassium level increased to greater than 5.5 mmol/L. Corresponding Author: To contact the corresponding author, Scott D. Solomon, MD, email ssolomon@rics.bwh.harvard.edu.  To access the embargoed study: Visit our ...

Hormone therapy reshapes the skeleton in transgender individuals who previously blocked puberty

2024-11-17
Skeletal size may be altered by gender-affirming hormone therapy only if puberty has also been suppressed during adolescence, according to research presented at the 62nd Annual European Society for Paediatric Endocrinology Meeting in Liverpool. The findings from this research, carried out by Amsterdam UMC, not only help researchers further understand the roles sex hormones play on the skeleton but may also improve counselling on gender-affirming treatment in transgender individuals. Skeletons of men and women vary in size and proportion. For instance, men typically have broader shoulders while women have a wider pelvis. Gender-affirming hormones ...

Evaluating performance and agreement of coronary heart disease polygenic risk scores

2024-11-16
About The Study: Coronary heart disease polygenic risk scores that performed similarly at the population level demonstrated highly variable individual-level estimates of risk. Recognizing that coronary heart disease polygenic risk scores may generate incongruent individual-level risk estimates, effective clinical implementation will require refined statistical methods to quantify uncertainty and new strategies to communicate this uncertainty to patients and clinicians.  Corresponding Author: To contact the corresponding author, Scott M. Damrauer, MD, email Scott.Damrauer@pennmedicine.upenn.edu. To access the embargoed study: Visit our For The Media website at this link ...

Heart failure in zero gravity— external constraint and cardiac hemodynamics

2024-11-16
About The Study: In this case series study, pulmonary artery systolic, diastolic, and mean pressures of 2 participants with obesity and heart failure with preserved ejection fraction were measured at zero gravity during parabolic flight to assess the effect of external constraint on left ventricular filling pressures.  Corresponding Author: To contact the corresponding author, Benjamin D. Levine, MD, email benjaminlevine@texashealth.org. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/   (doi:10.1001/jamacardio.2024.4596) Editor’s Note: Please see the article for additional information, including ...

Amid record year for dengue infections, new study finds climate change responsible for 19% of today’s rising dengue burden

2024-11-16
NEW ORLEANS (November 16, 2024) — Climate change is having a massive global impact on dengue transmission, accounting for 19% of the current dengue burden, with a potential to spark an additional 40%-60% spike by 2050 — and by as much as 150%-200% in some areas — according to a new study presented today at the Annual Meeting of the American Society of Tropical Medicine and Hygiene (ASTMH). The findings from researchers at Stanford and Harvard Universities offer the most definitive evidence to date that climate change is ...

New study finds air pollution increases inflammation primarily in patients with heart disease

New study finds air pollution increases inflammation primarily in patients with heart disease
2024-11-16
A new study by heart researchers at Intermountain Health in Salt Lake City finds that patients with heart disease, specifically those with heart failure, are especially vulnerable to the impacts of air pollution and poor air quality and can take steps to protect themselves.  Results from the Intermountain Health study, presented on Saturday at the American Heart Association’s 2024 Scientific Sessions international conference in Chicago, found that two inflammatory markers — CCL27 (C-C motif chemokine ligand 27) ...

AI finds undiagnosed liver disease in early stages

2024-11-16
SAN DIEGO, California (Nov. 16, 2024) — Liver disease, which is treatable when discovered early, often goes undetected until late stages, but a new study revealed that an algorithm fueled by artificial intelligence can accurately detect early-stage metabolic-associated steatotic liver disease (MASLD) by using electronic health records. The study was scheduled for presentation today at The Liver Meeting, hosted by the American Association for the Study of Liver Diseases. “A significant proportion of patients who meet criteria for MASLD go undiagnosed,” said Ariana Stuart MD, a resident at University of Washington Internal Medicine ...

LAST 30 PRESS RELEASES:

APS and SPR honor Dr. Wendy K. Chung with the 2026 Mary Ellen Avery Neonatal Research Award

The Gabriella Miller Kids First Data Resource Center (Kids First DRC) has launched the Variant Workbench

Yeast survives Martian conditions

Calcium could be key to solving stability issues in sodium-ion batteries

Can smoother surfaces prevent hydrogen embrittlement?

Heart rate changes predict depression treatment success with magnetic brain stimulation

Genetics pioneer transforms global depression research through multi-omics discoveries

MDMA psychiatric applications synthesized: Comprehensive review examines PTSD treatment and emerging therapeutic indications

Psychedelics offer new therapeutic framework for stress-related psychiatric disorders

Brain cell discoveries reshape understanding of psychiatric disorders

Mom’s voice boosts language-center development in preemies’ brains, study finds

Development of silicon ultrasound patch achieves both eco-friendliness and performance enhancement

Measles immunity 90% in BC’s Lower Mainland

Women’s brain regions may lose ability to synchronize after sexual assault

Quitting smoking, even late in life, linked to slower cognitive decline

Critical raw materials are a vital new currency; Europe’s e-waste is the vault

Anesthesiologist-led care helps hip-fracture patients get to surgery faster, with fewer complications

Two-dose recombinant shingles vaccine is effective even accounting for prior receipt of live shingles vaccine

Excessive daytime sleepiness may raise risk of cognitive problems after surgery

Flipping the switch on sperm motility offers new hope for male infertility

Twisting sound: Scientists discover a new way to control mechanical vibrations in metamaterial

Drip by drip: The hidden blueprint for stalagmite growth

mRNA therapy restores sperm production and fertility in mice

New way to weaken cancer cells could supercharge prostate cancer treatment

How sound—but not touch—shapes rhythm in the brain

Exploring the therapeutic potential of hypothermia

Research alert: Bioengineering breathes new life into failed cancer treatment

AI, health, and health care today and tomorrow – the JAMA Summit Report on artificial intelligence

Large genetic study links cannabis use to psychiatric, cognitive and physical health

Social media use trajectories and cognitive performance in adolescents

[Press-News.org] Innovative risk score accurately calculates which kidney transplant candidates are also at risk for heart attack or stroke, new study finds